Skip to content

Effects of Combined Acupuncture and Cupping Therapy on Serum Inflammatory Cytokines and Neuropathic Damage Markers in Patients with Acute Herpes Zoster

Effects of Combined Acupuncture and Cupping Therapy on Serum Inflammatory Cytokines and Neuropathic Damage Markers in Patients with Acute Herpes Zoster: A Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002636
Enrollment
Unknown
Registered
2025-12-30
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster

Interventions

Control group (conventional Western medicine treatment):Antiviral treatment, analgesic treatment, neurotrophic treatment, local care
Experimental group (conventional Western medicine treatment + acupuncture combined with cupping therapy):Conventional Western medicine treatment was compared with the control group, acupuncture treatm

Sponsors

Beijing Integrated Traditional Chinese and Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) According to the diagnostic criteria for herpes zoster in the fourth edition of "Chinese Dermatology and Venereology", it was confirmed as acute herpes zoster based on clinical manifestations and virological tests. 2) Age range: 18 - 75 years old. 3) The time from the appearance of the rash to enrollment is no more than 5 days. 4) Voluntary participation in this study, complete clinical data, and willingness to follow the treatment plan and the requirements for follow-up.

Exclusion criteria

Exclusion criteria: 1) Those with acquired or primary immunodeficiency diseases, including those with HIV infection or organ transplant recipients; 2) Those who have used glucocorticoids or immunosuppressants within the last 3 months; 3) Those with severe cardiovascular or cerebrovascular diseases, liver or kidney dysfunction, or mental disorders; 4) Those with extensive acute skin damage (such as burns), systemic infections, or skin diseases prone to infection; 5) Pregnant or lactating women; 6) Those with a history of allergic reactions or severe adverse reactions related to acupuncture or cupping therapy; 7) Those currently participating in other concurrent clinical intervention trials.

Design outcomes

Primary

MeasureTime frame
TNF-a;

Countries

China

Contacts

Public ContactRan Gao

Beijing Integrated Traditional Chinese and Western Medicine Hospital

267187957@qq.com18810755718

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026